Establishing a screening programme for diabetic retinopathy in Kilimanjaro Region, Tanzania using intervention mapping.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
24
5
2022
Statut:
ppublish
Résumé
The Kilimanjaro Diabetic Programme used the Intervention Mapping framework to develop a theory- and evidence-based diabetic retinopathy screening programme. A Working Committee of health care workers and stakeholders ensured community engagement and empowerment of the target audience. To deliver a culturally appropriate, sustainable, community supported health intervention, promoting eye health behaviour change, to prevent avoidable blindness. The six steps of the Intervention Mapping protocol incorporated eight components: (1) a needs assessment of people with diabetes and health care workers (2) a clinical trial of diabetic retinopathy screening modes, (3) comic strips as a motivational strategy for diabetic retinopathy screening uptake, (4) health care worker education (5) an electronic database of people with diabetes (6) a self-carry diary (7) implementation of mobile diabetic retinopathy retinal screening (8) process and outcome programme evaluation. The programme eliminated barriers to diabetic retinopathy screening in Kilimanjaro Christian Medical Centre eye and diabetic clinics, placing a digital retinal screening camera in the diabetic clinic and a fast-track screening system in the eye clinic. Two comic strips and a diary provided information about self-management and record of medications, treatment, blood sugar and blood pressure at clinic visits. An annual rural health care worker education programme met requests for knowledge on treatment and care of diabetes, targeting prevention of diabetic retinopathy. Rural digital retinal screening was implemented. Rural diabetes clinics were initiated. Intervention Mapping provided a systematic, iterative model to formulate and deliver an urban and rural diabetic retinopathy screening programme. ISRCTN31439939. Details available at https://www.isrctn.com/.
Sections du résumé
BACKGROUND
The Kilimanjaro Diabetic Programme used the Intervention Mapping framework to develop a theory- and evidence-based diabetic retinopathy screening programme. A Working Committee of health care workers and stakeholders ensured community engagement and empowerment of the target audience.
OBJECTIVES
To deliver a culturally appropriate, sustainable, community supported health intervention, promoting eye health behaviour change, to prevent avoidable blindness.
METHODS
The six steps of the Intervention Mapping protocol incorporated eight components: (1) a needs assessment of people with diabetes and health care workers (2) a clinical trial of diabetic retinopathy screening modes, (3) comic strips as a motivational strategy for diabetic retinopathy screening uptake, (4) health care worker education (5) an electronic database of people with diabetes (6) a self-carry diary (7) implementation of mobile diabetic retinopathy retinal screening (8) process and outcome programme evaluation.
RESULTS
The programme eliminated barriers to diabetic retinopathy screening in Kilimanjaro Christian Medical Centre eye and diabetic clinics, placing a digital retinal screening camera in the diabetic clinic and a fast-track screening system in the eye clinic. Two comic strips and a diary provided information about self-management and record of medications, treatment, blood sugar and blood pressure at clinic visits. An annual rural health care worker education programme met requests for knowledge on treatment and care of diabetes, targeting prevention of diabetic retinopathy. Rural digital retinal screening was implemented. Rural diabetes clinics were initiated.
CONCLUSIONS
Intervention Mapping provided a systematic, iterative model to formulate and deliver an urban and rural diabetic retinopathy screening programme.
TRIAL REGISTRATION NUMBER
ISRCTN31439939. Details available at https://www.isrctn.com/.
Identifiants
pubmed: 35590051
doi: 10.1038/s41433-022-02001-w
pii: 10.1038/s41433-022-02001-w
pmc: PMC9159027
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17-24Informations de copyright
© 2022. The Author(s).
Références
Arch Ophthalmol. 1985 Dec;103(12):1796-806
pubmed: 2866759
Br J Sports Med. 2010 Feb;44(2):121-6
pubmed: 18523037
BMC Res Notes. 2016 Feb 01;9:56
pubmed: 26829927
Health Promot Int. 2018 Oct 1;33(5):901-911
pubmed: 28369557
Lancet Diabetes Endocrinol. 2015 Sep;3(9):675-7
pubmed: 26201978
BMC Med. 2013 Jul 02;11:157
pubmed: 23819888
BMC Ophthalmol. 2016 Jul 19;16:115
pubmed: 27435362
Lancet. 2010 Jun 26;375(9733):2254-66
pubmed: 20609971
Int J Health Policy Manag. 2016 Aug 15;6(2):111-113
pubmed: 28812787
Psicol Reflex Crit. 2017 Oct 18;30(1):19
pubmed: 32026109
Lancet Diabetes Endocrinol. 2016 Jan;4(1):10-2
pubmed: 26656290
Surv Ophthalmol. 2012 Jul-Aug;57(4):347-70
pubmed: 22542913
PLoS One. 2015 Jul 08;10(7):e0127199
pubmed: 26154083
Ophthalmic Epidemiol. 2007 Sep-Oct;14(5):306-10
pubmed: 17994440
PLoS One. 2014 Sep 12;9(9):e106716
pubmed: 25216268
Ophthalmology. 1981 Jul;88(7):583-600
pubmed: 7196564
Int J Equity Health. 2013 Aug 20;12:63
pubmed: 23962055
Int J Environ Res Public Health. 2010 Feb;7(2):675-97
pubmed: 20616997